We are a Fintech startup based in Austin, Texas. We are an investment management firm specialized in the healthcare sector.
A world with healthcare access.
We envision a world with complete transparency regarding healthcare issues, an ecosystem to solve those problems.

A world with healthcare access.
We envision a world with complete transparency regarding healthcare issues, an ecosystem to solve those problems.

Investment management firm specialized in the Healthcare sector.
We envision a world with complete transparency regarding healthcare issues, an ecosystem to solve those problems.
A world with healthcare access
We envision a world with complete transparency regarding healthcare issues, an ecosystem to solve those problems.

Healthcare Money Asset (HMA)
Healthcare Money Asset (HMA) is an Ethereum Token that powers the transformation of healthcare. HMA is a stable coin linked to assets contained in a special index of the healthcare sector's most significant private and public companies, creating a new ecosystem intended to solve medical issues.
Hybrid Token
Hybrid Token
The HMA Coin is sustained by Healthcare assets in multiple forms, with the mission to create a stable coin with high income. The assets determine the value of the coin that it contains, in addition to the demand and offer of the coin.
Yes, its a Stablecoin
Yes, its a Stablecoin
It combines the greatest virtues of DeFi and Traditional Finance.
1:1 Invest
1:1 Invest
It will invest 100% of its total assets in healthcare securities of American and global companies. We will also invest in innovative private companies that will transform digital health.
Be Part of the Future
Be Part of the Future
It's the first currency on the market using this unique model, containing assets from the healthcare industry. The ultimate goal of the coin is to create a self-sufficient token that can be used in different layers of the health industry and day-to-day trading.
We Invest in Public Equity Markets
We Invest in Public Equity Markets
The main feature of the token is to invest in public equity markets of the United States and the World. The investment seeks results that correspond to the price and yield performance of publicly traded equity securities of companies in the healthcare sector.
We envision a hybrid economy
With a fusion of the new technology of blockchain and the safety that smart contracts offer to securities in U.S. and global markets of healthcare companies.




We envision a hybrid economy
With a fusion of the new technology of blockchain and the safety that smart contracts offer to securities in U.S. and global markets of healthcare companies.





Why Chose Us?
We are on a mission to change healthcare for good. Through the years, the healthcare industry has remained in the shadows in terms of investment transparency due to the lack of precise info released. We seek to create an investment firm that allows people to know and understand the medical investment. Also, through our token, we ensure that the investor has an asset with a growing and stable value.

Why Chose Us?
We are on a mission to change healthcare for good. Through the years, the healthcare industry has remained in the shadows in terms of investment transparency due to the lack of precise info released. We seek to create an investment firm that allows people to know and understand the medical investment. Also, through our token, we ensure that the investor has an asset with a growing and stable value.

Healthcare transformation
We intend to create a revolution in healthcare, looking for novel and groundbreaking ideas. So we are creating an open platform where people can share their ideas with us and make them possible.
The future is here, keep updated.

May 12, 2022
Astra Zeneca. “Lynparza” is a light at the end of the tunnel for triple-negative breast cancer.
The FDA has approved the first drug against the mortal type of breast cancer. Lynparza, unlike its predecessors, treats HER2/neu negative cancer, which has been increasing in the last years, giving hope to patients suffering from this terrible disease.

April 28, 2022
Biogen’s big blow on its top seller
Biogen's big seller drug Adulhem has been retired from Medicare and Medicaid after failing to prove a real benefit to the patients suffering from Alzheimer's disease. Is this going to affect the market value of Biogen? What is next in the Alzheimer's medication?

January 28, 2022
“Intuitive Surgical” first sign of concern?
Intuitive surgical, the giant of robotic surgery has suffered a big blow on its quarterly goals by not reaching its equipment placement expected. Is this a sign of concern for the upcoming future of the massive company?